(5S,6S,10R)-10-(2,4-Dichloro­phen­yl)-14-[(E)-(2,4-dichloro­phen­yl)methyl­idene]-3,9-diphenyl-12-[(R)-1-phenyl­ethyl]-1,4,7-trioxa-2,8,12-triaza­dispiro­[4.0.4.4]tetra­deca-2,8-diene

The asymmetric unit of the title compound, C(41)H(31)Cl(4)N(3)O(3), contains two independent mol­ecules with almost identical geometries. The piperidine ring adopts a chair conformation in both mol­ecules, and the dihydro­isoxazole rings adopt envelope conformations. The crystal structure is stabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahalakshmi, S., Kumar, R. Suresh, Perumal, S., Sivakumar, V., Suresh, J.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2007
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915262/
https://www.ncbi.nlm.nih.gov/pubmed/21200764
http://dx.doi.org/10.1107/S1600536807063477
Descripción
Sumario:The asymmetric unit of the title compound, C(41)H(31)Cl(4)N(3)O(3), contains two independent mol­ecules with almost identical geometries. The piperidine ring adopts a chair conformation in both mol­ecules, and the dihydro­isoxazole rings adopt envelope conformations. The crystal structure is stabilized by C—H⋯N hydrogen bonds and C—H⋯π inter­actions.

Ejemplares similares